Evidence map›Paper›PMID 38512564›Full record

ArticleJournal of cancer survivorship : research and practice2025

Barriers and facilitators to self-management in people living with a lower-grade glioma.

Ben Rimmer, Michelle Balla, Lizzie Dutton, Sophie Williams, Vera Araújo-Soares, Pamela Gallagher, Tracy Finch, Joanne Lewis, Richéal Burns, Fiona Menger and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Mapping Cognitive Oncology: A Decade of Trends and Research Fronts.Medical sciences (Basel, Switzerland) · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Ben RimmerPopulation Health Sciences Institute, Newcastle University, Newcastle University Centre for Cancer, Ridley Building 1, Newcastle Upon Tyne, NE1 7RU, England. ben.rimmer@newcastle.ac.uk.
Michelle BallaFaculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, England.
Lizzie DuttonPopulation Health Sciences Institute, Newcastle University, Newcastle University Centre for Cancer, Ridley Building 1, Newcastle Upon Tyne, NE1 7RU, England.
Sophie WilliamsNewcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, England.
Vera Araújo-SoaresPopulation Health Sciences Institute, Newcastle University, Newcastle University Centre for Cancer, Ridley Building 1, Newcastle Upon Tyne, NE1 7RU, England.
Pamela GallagherSchool of Psychology, Dublin City University, Dublin, Ireland.
Tracy FinchDepartment of Nursing, Midwifery and Health, Northumbria University, Newcastle Upon Tyne, England.
Joanne LewisNewcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, England.
Richéal BurnsFaculty of Science, Atlantic Technological University, Sligo, Ireland.
Fiona MengerSchool of Education, Communication and Language Sciences, Newcastle University, Newcastle Upon Tyne, England.
Linda SharpPopulation Health Sciences Institute, Newcastle University, Newcastle University Centre for Cancer, Ridley Building 1, Newcastle Upon Tyne, NE1 7RU, England.
Ways Ahead study team
Newcastle University · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBAtlantic Technological UniversityDublin City University · IENorthumbria University · GBUniversity Hospital Heidelberg · DE

Funding

Brain Tumour Charity GN-000435
6 · The paper itself

Abstract

purposeSelf-management can have clinical and quality-of-life benefits. However, people with lower-grade gliomas (LGG) may face chronic tumour- and/or treatment-related symptoms and impairments (e.g. cognitive deficits, seizures), which could influence their ability to self-manage. Our study aimed to identify and understand the barriers and facilitators to self-management in people with LGG.

methodsWe conducted semi-structured interviews with 28 people with LGG across the United Kingdom, who had completed primary treatment. Sixteen participants were male, mean age was 50.4 years, and mean time since diagnosis was 8.7 years. Interviews were audio-recorded and transcribed. Following inductive open coding, we deductively mapped codes to Schulman-Green et al.'s framework of factors influencing self-management, developed in chronic illness.

resultsData suggested extensive support for all five framework categories ('Personal/lifestyle characteristics', 'Health status', 'Resources', 'Environmental characteristics', 'Healthcare system'), encompassing all 18 factors influencing self-management. How people with LGG experience many of these factors appears somewhat distinct from other cancers; participants described multiple, often co-occurring, challenges, primarily with knowledge and acceptance of their incurable condition, the impact of seizures and cognitive deficits, transport difficulties, and access to (in)formal support. Several factors were on a continuum, for example, sufficient knowledge was a facilitator, whereas lack thereof, was a barrier to self-management.

conclusionsPeople with LGG described distinctive experiences with wide-ranging factors influencing their ability to self-manage. IMPLICATIONS FOR CANCER SURVIVORS: These findings will improve awareness of the potential challenges faced by people with LGG around self-management and inform development of self-management interventions for this population.

Indexed as

Brain NeoplasmsGliomaSelf-ManagementAdultAgedFemaleHumansMaleMiddle AgedQuality of LifeUnited KingdomBarriersFacilitatorsLower-grade gliomaSelf-management

Identifiers

PMID38512564
PMCPMC12460353
OpenAlexW4393038405

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.